AQUILANT ENDOSCOPY LIMITED
Get an alert when AQUILANT ENDOSCOPY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
—
Equity attributable
Employees
31
0% vs 2024
Profit before tax
£13m
+1,554.9% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Accounts not prepared on a going-concern basis
Since that date, the directors have made the decision for the company to cease trading and become dormant and therefore the financial statements have been prepared on an 'other than going concern basis' as required by Financial Reporting Standard 102 Section 3. The directors have taken a prudent approach to preparing the financial statements with assets being written down to their estimated realisable amounts.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-30
| Metric | Trend | 2023-12-30 | 2024-12-30 | 2025-12-30 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £13,249,000 | £14,506,000 | £12,466,000 | -14.1% | |
| Operating profit | £668,000 | £727,000 | £12,944,000 | +1,680.5% | |
| Profit before tax | £684,000 | £796,000 | £13,173,000 | +1,554.9% | |
| Net profit | £509,000 | £640,000 | £9,890,000 | +1,445.3% | |
| Cash | — | £2,629,000 | — | — | |
| Total assets less current liabilities | £7,279,000 | £8,005,000 | — | — | |
| Net assets | £7,279,000 | £7,919,000 | — | — | |
| Equity | £7,279,000 | £7,919,000 | — | — | |
| Average employees | 31 | 31 | 31 | 0% | |
| Wages | £1,523,000 | £1,554,000 | £1,418,000 | -8.8% | |
| Directors' remuneration | £52,000 | £88,000 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-30 | 2024-12-30 | 2025-12-30 |
|---|---|---|---|---|
| Operating margin | 5.0% | 5.0% | 103.8% | |
| Net margin | 3.8% | 4.4% | 79.3% | |
| Return on capital employed | 9.2% | 9.1% | — | |
| Gearing (liabilities / total assets) | 46.3% | 39.9% | — | |
| Current ratio | 2.10x | 2.40x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- AQUILANT ENDOSCOPY LIMITED 2014-10-24 → present
- IMOTECH MEDICAL LIMITED 2010-02-08 → 2014-10-24
- ENDOSCOPY UK LIMITED 1997-07-11 → 2010-02-08
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Cooper Parry Group Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Not a going concern (break-up basis)
“Since that date, the directors have made the decision for the company to cease trading and become dormant and therefore the financial statements have been prepared on an 'other than going concern basis' as required by Financial Reporting Standard 102 Section 3. The directors have taken a prudent approach to preparing the financial statements with assets being written down to their estimated realisable amounts.”
Significant events
- “On 1 December 2025 a substantial portion of the trade of the company was sold to a third party for consideration of £12,208,000. Immediately following this the remaining trade and assets of the company were hived across to another group company, Aquilant Limited. From that date, the company has ceased to trade.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ARUNDEL, Stephen | Director | 2024-02-15 | Sep 1970 | British |
| DREELAN, Darragh | Director | 2024-02-15 | Jun 1992 | Irish |
| PETTITT, Nathan | Director | 2022-12-31 | Sep 1971 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRETON, Angus Roy Mackenzie | Secretary | 1998-07-09 | 2000-09-08 |
| DAVIS, Keith Michael | Secretary | 2000-09-08 | 2006-05-05 |
| GANNON, Michael | Secretary | 2013-04-01 | 2014-05-20 |
| GEOGHEGAN, Karen | Secretary | 2007-07-20 | 2013-04-01 |
| GIBSON, Jacqueline | Secretary | 1997-07-11 | 1997-12-01 |
| GRIMLEY, Tara | Secretary | 2014-05-20 | 2017-05-03 |
| HEELEY, Claire | Secretary | 2006-05-05 | 2007-07-20 |
| MOYNAGH, Damien | Secretary | 2017-05-03 | 2018-08-07 |
| SWINNEY, Paul Christopher | Secretary | 1997-12-01 | 1998-07-09 |
| HALLMARK SECRETARIES LIMITED | Corporate Nominee Secretary | 1997-07-11 | 1997-07-11 |
| BENTLEY, John Anthony | Director | 2013-10-30 | 2018-09-30 |
| BOLAND, David | Director | 2023-04-28 | 2024-02-15 |
| BREHONY, Luke | Director | 2006-05-05 | 2009-08-21 |
| BRETON, Anthony Moyle | Director | 1998-12-18 | 2005-09-19 |
| COYLE, Sean Gerard | Director | 2015-10-01 | 2018-06-30 |
| DAVIS, Andrew James | Director | 2009-08-26 | 2010-07-20 |
| DEMPSEY, Padraic | Director | 2013-06-01 | 2013-10-30 |
| DEW, Richard | Director | 2018-08-07 | 2020-09-17 |
| FREDERICK, David Charles | Director | 2018-10-03 | 2023-04-20 |
| KALVERBOER, Patrick Henricus Lambertus | Director | 2018-08-07 | 2018-10-03 |
| MCGRANE, Barry | Director | 2006-11-30 | 2013-05-31 |
| OWENS, Pj | Director | 2018-08-07 | 2019-06-21 |
| PUTTOCK, Luke Benjamin | Director | 2005-10-31 | 2006-05-05 |
| PUTTOCK, Matt | Director | 2003-01-01 | 2006-11-30 |
| PUTTOCK, Raymond | Director | 2006-05-05 | 2006-05-05 |
| PUTTOCK, Raymond | Director | 1997-12-01 | 2003-01-01 |
| RALPH, Alan | Director | 2013-06-01 | 2013-06-01 |
| RALPH, Alan | Director | 2009-08-21 | 2018-08-07 |
| RODGERS, Trevor | Director | 2019-06-21 | 2023-04-28 |
| SOLER, Francisco Angel | Director | 1998-07-09 | 1998-12-17 |
| SWINNEY, Paul Christopher | Director | 1997-07-11 | 1998-07-09 |
| WILSON, Duncan | Director | 2006-05-05 | 2007-05-29 |
| HALLMARK REGISTRARS LIMITED | Corporate Nominee Director | 1997-07-11 | 1997-07-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Addlife Ab (Publ) | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-04-12 | Active |
| Healthcare Acquisition Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-08-07 | Ceased 2018-08-07 |
| Udg Healthcare (Uk) Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2018-06-05 | Ceased 2018-08-07 |
| Mr Alan Ralph | Individual | Significant influence, Significant influence (as firm) | 2016-06-30 | Ceased 2018-06-05 |
| Mr Sean Coyle | Individual | Significant influence, Significant influence (as firm) | 2016-06-30 | Ceased 2018-06-05 |
Filing timeline
Last 20 of 175 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-03 | AA | accounts | Accounts with accounts type full | |
| 2025-10-27 | AA | accounts | Accounts with accounts type full | |
| 2025-10-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-06 | AA | accounts | Accounts with accounts type full | |
| 2024-06-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-05-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-29 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-29 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-14 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-09-12 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-06-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-21 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-08 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-08 | TM01 | officers | Termination director company with name termination date | |
| 2023-03-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-09-27 | AA | accounts | Accounts with accounts type full | |
| 2022-06-13 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.